Anjana Yeldandi

Anjana Yeldandi

Auto-generated profile, based on publicly available information

Anjana Yeldandi

Department of Pathology, Feinberg School of Medicine Northwestern University, 676 North St. Clair Street, Chicago, IL 60611, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SSSailesh Surapureddi
Sailesh Surapureddi
SYSongtao Yu
Songtao Yu
HBHengfu Bu
Hengfu Bu
Takashi HashimotoTakashi Hashimoto
Takashi Hashimoto
AYAnjana V. Yeldandi
Anjana V. Yeldandi
JRJanardan Reddy
Janardan Reddy
Peroxisome proliferator-activated receptor α (PPARα) plays a central role in the cell-specific pleiotropic responses induced by structurally diverse synthetic chemicals designated as peroxisome proliferators. Transcriptional regulation by liganded nuclear receptors involves the participation of cofactors that form multiprotein complexes to achieve cell- and gene-specific transcription. Here we report the identification of such a transcriptionally active PPARα-interacting cofactor (PRIC) complex from rat liver nuclear extracts that interacts with full-length PPARα in the presence of ciprofibrate, a synthetic ligand, and leukotriene B4, a natural ligand. The liganded PPARα-PRIC complex enhanced transcription from a peroxisomal enoyl-CoA hydratase/l-3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme gene promoter template that contains peroxisome proliferator response elements. Rat liver PRIC complex comprises some 25 polypeptides, and their identities were established by mass spectrometry and limited sequence analysis. Eighteen of these peptides contain one or more LXXLL motifs necessary for interacting with nuclear receptors. PRIC complex includes known coactivators or coactivator-binding proteins (CBP, SRC-1, PBP, PRIP, PIMT, TRAP100, SUR-2, and PGC-1), other proteins that have not previously been described in association with transcription complexes (CHD5, TOG, and MORF), and a few novel polypeptides designated PRIC300, -285, -215, -177, and -145. We describe the cDNA for PRIC285, which contains five LXXLL motifs. It interacts with PPARα and acts as a coactivator by moderately stimulating PPARα-mediated transcription in transfected cells. We conclude that liganded PPARα recruits a distinctive multiprotein complex from rat liver nuclear extracts. The composition of this complex may provide insight into the basis of tissue and species sensitivity to peroxisome proliferators.

8 March 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
DXDan Xu
Dan Xu
Swati BhattacharyyaSwati Bhattacharyya
Swati Bhattacharyya
WWWenxia Wang
Wenxia Wang
Igal IferganIgal Ifergan
Igal Ifergan
MWMing-Yi Alice Chiang Wong
Ming-Yi Alice Chiang Wong
JVJohn Varga
John Varga
Systemic sclerosis (SSc) is a chronic, multisystem orphan disease with a highly variable clinical course, high mortality rate, and a poorly understood complex pathogenesis. We have identified an important role for a subpopulation of monocytes and macrophages characterized by surface expression of the scavenger receptor macrophage receptor with collagenous structure (MARCO) in chronic inflammation and fibrosis in SSc and in preclinical disease models. We show that MARCO + monocytes and macrophages accumulate in lesional skin and lung in topographic proximity to activated myofibroblasts in patients with SSc and in the bleomycin-induced mouse model of SSc. Short-term treatment of mice with a potentially novel nanoparticle, poly(lactic- co -glycolic) acid (PLG), which is composed of a carboxylated, FDA-approved, biodegradable polymer and modulates activation and trafficking of MARCO + inflammatory monocytes, markedly attenuated bleomycin-induced skin and lung inflammation and fibrosis. Mechanistically, in isolated cells in culture, PLG nanoparticles inhibited TGF-dependent fibrotic responses in vitro. Thus, MARCO + monocytes are potent effector cells of skin and lung fibrosis and can be therapeutically targeted in SSc using PLG nanoparticles.

1 January 1992 in Cytogenetic and Genome Research
Verified
Journal Article
Closed access
PDF file
AYA.V. Yeldandi
A.V. Yeldandi
YPY.D. Patel
Y.D. Patel
MLM. Liao
M. Liao
FKF.T. Kao
F.T. Kao
MRM.S. Rao
M.S. Rao
MBM.M. Le Beau
M.M. Le Beau
The human urate oxidase (E.C. 1.7.3.3) gene, UOX, is assigned to chromosome 1 by Southern analysis of human × hamster cell hybrids. Using fluorescent in situ hybridization, we have mapped this gene to 1p22.

27 October 2020 in medRxiv
Verified
Preprint
Open access
PDF file
ABAnkit Bharat
Ankit Bharat
MQMelissa Querrey
Melissa Querrey
NMNikolay S. Markov
Nikolay S. Markov
SKSamuel Kim
Samuel Kim
CKChitaru Kurihara
Chitaru Kurihara
GBG.R. Scott Budinger
G.R. Scott Budinger
Lung transplantation can potentially be a life-saving treatment for patients with non-resolving COVID-19 acute respiratory distress syndrome. Concerns limiting transplant include recurrence of SARS-CoV-2 infection in the allograft, technical challenges imposed by viral-mediated injury to the native lung, and potential risk for allograft infection by pathogens associated with ventilator-induced pneumonia in the native lung. Additionally, the native lung might recover, resulting in long-term outcomes preferable to transplant. Here, we report the results of the first two successful lung transplantation procedures in patients with non-resolving COVID-19 associated acute respiratory distress syndrome in the United States. We performed smFISH to detect both positive and negative strands of SARS-CoV-2 RNA in the explanted lung tissue, extracellular matrix imaging using SHIELD tissue clearance, and single cell RNA-Seq on explant and warm post-mortem lung biopsies from patients who died from severe COVID-19 pneumonia. Lungs from patients with prolonged COVID-19 were free of virus but pathology showed extensive evidence of injury and fibrosis which resembled end-stage pulmonary fibrosis. Single cell RNA-Seq of the explanted native lungs from transplant and paired warm post-mortem autopsies showed similarities between late SARS-CoV-2 acute respiratory distress syndrome and irreversible end-stage pulmonary fibrosis requiring lung transplantation. There was no recurrence of SARS-CoV-2 or pathogens associated with pre-transplant ventilator associated pneumonias following transplantation in either patient. Our findings suggest that some patients with severe COVID-19 develop fibrotic lung disease for which lung transplantation is the only option for survival. Single sentence summary Some patients with severe COVID-19 develop end-stage pulmonary fibrosis for which lung transplantation may be the only treatment.

1 August 2015 in The Annals of Thoracic Surgery
Verified
Journal Article
Open access
CMChristopher K. Mehta
Christopher K. Mehta
CGColin T. Gillespie
Colin T. Gillespie
XLXiaoqi Lin
Xiaoqi Lin
AYAnjana Yeldandi
Anjana Yeldandi
MDMalcolm DeCamp
Malcolm DeCamp
ABAnkit Bharat
Ankit Bharat
Mediastinal paragangliomas are rare neural crest derived tumors that may produce symptoms of excess catecholamine production or mass effect. Paragangliomas can histologically mimic neuroendocrine tumors. Further, both can arise in similar locations. We report a patient who presented with a right upper lobe as well as middle mediastinal lesion. Preoperative biopsy as well as intraoperative frozen section of these lesions failed to distinguish between paraganlioma or neuroendocrine tumor, necessitating a right upper lobectomy and complete mediastinal lymphadenectomy. Final pathology revealed carcinoid tumorlets in the right upper lobe and a middle mediastinal paraganglioma.

1 January 1994 in Carcinogenesis
Verified
Journal Article
Closed access
MRM.Sambasiva Rao
M.Sambasiva Rao
HIHideyuki Ide
Hideyuki Ide
AYAnjana V. Yeldandi
Anjana V. Yeldandi
SKSujata Kumar
Sujata Kumar
JRJanardan K. Reddy
Janardan K. Reddy
We have examined ciprofibrate and dehydroepiandrosterone (DHEA)-induced hepatic lesions for the peroxisomal beta-oxidation system enzyme peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (PBE) and its mRNA using SDS-polyacrylamide gel electrophoresis, antibodies and cDNA probe. All 12 neoplastic nodules and nine hepatocellular carcinomas (HCCs) that were analyzed for PBE mRNA by in situ hybridization showed an intense signal comparable to the adjacent non-neoplastic liver. SDS-polyacrylamide gel electrophoresis of postnuclear fractions of six HCC and adjacent liver tissue showed a marked increase in an 80 kDa polypeptide. Immunoblot and Northern blot analysis showed a marked increase in PBE enzyme and PBE mRNA respectively in HCC and adjacent non-neoplastic liver tissue. In control livers (animals not treated with peroxisome proliferators), the levels of PBE enzyme and mRNA were very low or undetectable. The results of this study clearly indicate that peroxisome proliferator (PP)-induced liver lesions express peroxisomal enzymes to the same extent as adjacent liver and that these enzymes are not useful markers for identification of PP-induced lesions.